Medicare Enrolled
Dr. Farshid Mirzaee, MD
Urology Physician · Rancho Mirage, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mirzaee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mirzaee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mirzaee
Dr. Farshid Mirzaee is an urology physician in Rancho Mirage, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Mirzaee performed 2,978 Medicare services across 2,272 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mirzaee received a total of $6,883 from 36 pharmaceutical and/or device companies across 105 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mirzaee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 28% volume in CA
$6,883 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,978
Medicare services
Top 28% in CA for urology physician
2,272
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~186 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
540 | $99 | $375 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
529 | $47 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
438 | $69 | $325 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
285 | $9 | $60 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
227 | $124 | $450 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
137 | $45 | $150 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
124 | $0 | $20 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
84 | $194 | $850 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 72 | $137 | $700 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
61 | $122 | $1,200 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
49 | $96 | $356 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
45 | $141 | $650 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
40 | $52 | $240 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
31 | $28 | $90 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
26 | $116 | $650 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
26 | $11 | $75 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
24 | $309 | $1,200 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
24 | $6 | $75 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
24 | $164 | $850 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
23 | $27 | $300 |
| Simple change of bladder tube | 22 | $74 | $320 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
19 | $60 | $1,300 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
17 | $197 | $700 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
17 | $49 | $200 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
16 | $121 | $1,200 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
14 | $133 | $10,000 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
14 | $29 | $75 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
14 | $12 | $45 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
13 | $331 | $1,350 |
| Bladder tumor removal via endoscope This procedure involves using an endoscope to destroy or remove a large growth from the bladder. |
12 | $307 | $1,250 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
11 | $92 | $550 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.6% high complexity
36.3% medium
62.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,883
Total received (2018-2024)
Avg $983/year across 7 years
Top 26% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
105
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,633 (81.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,250 (18.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$818
2023
$1,900
2022
$801
2021
$389
2020
$436
2019
$734
2018
$1,805
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$158
MIMEDX Group, Inc.
$150
Abbott Laboratories
$136
INTUITIVE SURGICAL, INC.
$131
Boston Scientific Corporation
$121
ABBVIE INC.
$44
Dendreon Pharmaceuticals LLC
$35
Sumitomo Pharma America, Inc.
$27
Olympus America Inc.
$16
Top 3 companies account for 54.4% of 2024 payments
All-time payments by company (2018-2024) ›
Caldera Medical, Inc
$1,250
PALETTE LIFE SCIENCES, INC.
$1,138
Boston Scientific Corporation
$979
Abbott Laboratories
$651
Teleflex LLC
$480
BOSTON SCIENTIFIC CORPORATION
$270
Rochester Medical Corporation
$218
Astellas Pharma US Inc
$193
MIMEDX Group, Inc.
$150
NeoTract Inc.
$150
Telix Pharmaceuticals
$137
INTUITIVE SURGICAL, INC.
$131
Coloplast Corp
$125
Axonics, Inc.
$121
Integra LifeSciences Corporation
$118
Laborie Medical Technologies Corp.
$117
180 Medical, Inc.
$88
NxThera, Inc.
$82
Bayer HealthCare Pharmaceuticals Inc.
$78
ABBVIE INC.
$44
PFIZER INC.
$40
Intuitive Surgical, Inc.
$40
Janssen Biotech, Inc.
$36
Dendreon Pharmaceuticals LLC
$35
Sumitomo Pharma America, Inc.
$27
UROVANT SCIENCES INC
$26
AbbVie Inc.
$24
TOLMAR Pharmaceuticals, Inc.
$20
Endo Pharmaceuticals Inc.
$20
Agile Therapeutics, Inc.
$19
Novartis Pharmaceuticals Corporation
$17
Olympus America Inc.
$16
TherapeuticsMD, Inc.
$16
Agiliti Surgical, Inc.
$14
Avion Pharmaceuticals
$13
UROCURE LLC
$1
Top 3 companies account for 48.9% of all-time payments
Associated products mentioned in payments ›
ADVANCE · AFINITOR · AMS · Axium INS DRG IPG · Axonics · BIOFIX · BOTOX · Bulkamid · DRG IPGs · Da Vinci Surgical System · Desara · Divigel · ELIGARD · ETERNA · Erleada · GEMTESA · GENERAL - THERAPIES · GENTLECATH · General - BPH · GentleCath · ILLUCCIX · IMVEXXY · Isiris aStent Removal Device · Kyleena · LO LOESTRIN FE · MYRBETRIQ · Mirena · Nubeqa · OCTRODE · PREMARIN · PROCLAIM · PROVENGE · Proclaim Family of SCS IPGs · REZUM · Rezum · SPACEOAR · SYMPHION · TACTRA · Twirla · UROLIFT · UroLift · XIAFLEX · XTANDI · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
18
Per 100K population
0.7
County median income
$89,672
Nearest hospital
EISENHOWER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mirzaee is a clinical cardiology specialist, with above-average Medicare volume (top 28% in CA), with low-engagement industry engagement, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mirzaee experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mirzaee performed 540 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mirzaee receive payments from pharmaceutical companies?
Yes. Dr. Mirzaee received a total of $6,883 from 36 companies across 105 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mirzaee's costs compare to other urology physicians in Rancho Mirage?
Dr. Mirzaee's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mirzaee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Rancho Mirage
Browse urology physicians in Rancho Mirage ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Caldera Medical, Inc Payments to Doctors
See all physicians who received payments from Caldera Medical, Inc.
By company
PALETTE LIFE SCIENCES, INC. Payments to Doctors
See all physicians who received payments from PALETTE LIFE SCIENCES, INC.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology